InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,986.40
(
0.30%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.83
(
0.00%
)
Bitcoin
60,024.87
(
0.03%
)
Post# of 253124
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

10nisman

Send PM Follow Ignore
Followers 26
Posts 2533
Boards Moderated 0
Alias Born 10/26/2003

10nisman

Re: Biowatch post# 109858

Friday, 12/03/2010 1:04:51 AM

Friday, December 03, 2010 1:04:51 AM

Post# of 253124

Yes, impressive credentials, but TEVA's been around the block a few times regarding patent disputes. I respect a Harvard law Degree. Over and above that, he has excellent credentials. I respect what he's done, but what matters is what he can do for this case, and what his support staff can do to help.

NVS has been around the block a few times as well. IMHO, we can safely assume NVS/Sandoz will line-up a legal team equal to or better than Teva's. mLovenox is a very important for NVS/Sandoz and they will spend whatever is needed to support their position.

10nis
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up